Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860027 · ClinicalTrials.gov registry record
Eye Movements and Reading Disabilities
A clinical trial, sponsored by Scripps Health.
- Terminated
- Registry status
- 1
- Enrollment target
NCT01860027: Clinical Trial study, sponsored by Scripps Health.
NCT01860027 is a clinical trial that was terminated before completion, run by Scripps Health. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01860027 was terminated before completion, sponsored by Scripps Health.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The mechanism of the eye movement anomalies seen in dyslexic patients is not well defined. Some optometrists use observational eye movement tests as screening devices for dyslexia and advocate eye movement therapy as a treatment option for dyslexia. The reliability of the clinical eye movement tests and the efficacy of the eye movement therapies have not been determined. Saccades are the fast eye movements that move our eyes from one word to the next when we read. The eye movement recordings from patients diagnosed with reading disorders, extra ocular muscle imbalances and control patients (no learning disability or eye movement disorder) will be analyzed and compared. The sensitivity and specificity of detecting reading disorders will be determined for the Visagraph III and the Readalyzer. Although these clinical tests are frequently used to diagnose saccadic inaccuracies and diagnose dyslexia in school aged children, the validity of these clinical screening tests has not been determined.
Primary Outcome
The primary analysis will be determining the sensitivity and specificity of the eye movement recording devices to recognize reading disorders. The sensitivity (true positive rate) of the eye movement recorders will be determined by the ability of each device to recognize children with reading disorders in Group 1. The specificity of the recorders will be determined by calculating the false positives in group 2 (eye movement disorders), and group 3 (control subjects).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-09-01 |
Why NCT01860027 stopped before completion
NCT01860027 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01860027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01860027 about?
NCT01860027 is a clinical study titled "Eye Movements and Reading Disabilities". The mechanism of the eye movement anomalies seen in dyslexic patients is not well defined. Some optometrists use observational eye movement tests as screening devices for dyslexia and advocate eye movement therapy as a treatment option for dyslexia. The reliability of the clinical eye movement tests...
What is the current status of trial NCT01860027?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2013-12. Estimated completion is 2014-09-01.
Who is sponsoring clinical trial NCT01860027?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia